Ana Slipicevic

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMedical mycologyMedical virologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2026
Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage Signaling.

Eric Ramirez-Salazar, Ana Slipicevic, Marina Juraleviciute

|Mar 18, 2021
MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy.

Marina Juraleviciute, Jérémie Nsengimana, Julia Newton-Bishop

|Oct 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cells.

Marina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana

|Jul 03, 2018
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro.

Zhihui Wang, Mette S Førsund, Claes G Trope

Pageof 1

Frequent Collaborators

1 joint publications

Joanna Pozniak

1 joint publications

Vivi Ann Flørenes

1 joint publications

Marina Juraleviciute

1 joint publications

Eric Ramirez-Salazar